Form 4: Tharimmune Director Sanam Parikh Reports Stock Transaction

Sentiment:

SEC Form 4 Filing


Director Sanam Parikh of Tharimmune, Inc. reports the acquisition and disposal of 770 shares of common stock on May 15, 2025.

Summary

  • On May 15, 2025, Sanam Parikh, a director of Tharimmune, Inc., engaged in a transaction involving the company's common stock.
  • Parikh acquired 770 shares of common stock at a price of $1.3 per share.
  • Following the reported transaction, Parikh directly owns 770 shares of Tharimmune, Inc.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock transaction by a company director, with no inherent positive or negative sentiment.

Industry Context

This is a standard SEC Form 4 filing, which is a routine part of corporate governance and transparency, providing insight into the trading activities of company insiders.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding the trading activities of a company director.

Key Dates

DateDescription
05/15/2025Date of stock transaction (acquisition and disposal of shares)
05/16/2025Date of signature for the report

Keywords

Form 4, Tharimmune, Director, Stock transaction, Beneficial ownership, Sanam Parikh, THAR

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.